A first aid guide for caregivers, an app that allows patients to track epilepsy trends, and 3 more top epilepsy and seizure apps for primary care.
Investigational Nonopioid Beats Placebo in Phase 3 Trial: Daily Dose
Your daily dose of the clinical news you may have missed.
Distress Signals: How to Help a Clinician Colleague in Need
"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Rebekah Bernard, MD, a family physician and national speaker on physician wellness.
Heart Disease Remains Leading Cause of Death in US: Daily Dose
Primary Viewpoints Episode 19: Mobile Health Technology for Chronic Pain Management
"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Lynn Webster, MD, past president of the American Academy of Pain Medicine.
Vistagen Wins US Patent for Investigational NMDA Receptor Antagonist to Treat Neuropathic Pain
AV-101 is an orally bioavailable small molecule NMDA receptor antagonist with antinociceptive effects similar to gabapentin but with more a more favorable safety profile.
FDA Approves Nonopioid Journavx for Acute Pain: Daily Dose